| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/20/2010 | CN100582086C Compound towards target of cardiac muscle and preparation |
| 01/20/2010 | CN100582084C Hydrophobic polyamine analogs and methods for their use |
| 01/20/2010 | CN100581581C Technique for preparing Chinese traditional medicine and pills for clearing away heart-fire, dispersing phlegm, tranquilizing the mind, and reducing blood pressure |
| 01/20/2010 | CN100581577C Thrombus diminishing blood-pressure reducing preparation |
| 01/20/2010 | CN100581566C Chinese medicine preparation for treating arrhythmia |
| 01/20/2010 | CN100581564C Yang-nourishing five-saponins medicine for preventing and curing cardiovascular or cerebrovascular disease, and the prepartion and the method for preparing the same |
| 01/20/2010 | CN100581561C Asiatic moonseed extract, preparations, preparing method and use thereof |
| 01/20/2010 | CN100581559C Compound orally disintegrating tablet of red sage root, its preparation method and detection method |
| 01/20/2010 | CN100581556C Chinese traditional extraction and the function containing dammarane type four-ring triterpene sapogenin |
| 01/20/2010 | CN100581552C Compound puerarin for treating cardiovascular and cerebrovascular disease |
| 01/20/2010 | CN100581549C Sustained-release preparation containing hydrochlorothiazide and preparation method thereof |
| 01/20/2010 | CN100581547C Ranolazine sustained release tablets |
| 01/20/2010 | CN100581546C Medicament compound containing milrinone |
| 01/20/2010 | CN100581541C Utilization of extracts from racemosa rhizoma for producing estrogen-like organ-selective medicament for suppressing LHSP activity |
| 01/20/2010 | CN100581540C Isosorbide mononitrate timing quick-release and slow-release preparation |
| 01/19/2010 | US7649095 Piperidine derivatives and agent comprising the derivative as active ingredient |
| 01/19/2010 | US7649010 Carvedilol hydrobromide |
| 01/19/2010 | US7649008 Crystal of 4-(1-((4-methylbenzothiophen-3-yl)methyl)benzimidazol-2-ylthio)butanoic acid; has chymase inhibitory activity in living body and can be used as a preventive and/or remedy for inflammatory diseases, allergic diseases, respiratory tract diseases, circulatory diseases, or bone metabolic diseases |
| 01/19/2010 | US7649000 (2'S,2''R)-4-(2'-(2''-amino-3''-(4'''-ethoxyphenyl)propanoylamino)-3'-phenylpropanoyl-amino)piperidine- 1-carboxamidine; inflammatory bowel disease, arthritis, inflammation, septic shock, hypotension, cancer, adult respiratory distress syndrome, disseminated intravascular coagulation |
| 01/19/2010 | US7648999 Activator for peroxisome proliferator-activated receptor δ |
| 01/19/2010 | US7648986 Hypertension, atherosclerosis, restenosis, cerebral ischemia, cerebral vasospasm, or erectile dysfunction; 2-(5-chloro-2-thienyl)-N-(1H-indazol-5-yl)thieno[3,2-d]pyrimidin-4-amine |
| 01/19/2010 | US7648985 Oxabispidine compounds and their use in the treatment of cardiac arrhythmias |
| 01/19/2010 | US7648959 Methods and compositions for the treatment of diseases of the eye |
| 01/19/2010 | US7648707 Compositions and methods for treatment of microbial infections |
| 01/19/2010 | CA2368097C Amide derivatives of 3,4-dihydroquinazolinone compounds useful as cytokine inhibitors |
| 01/19/2010 | CA2353805C Use of phytanic acid for the treatment of diabetes |
| 01/14/2010 | WO2010006184A2 Small-molecule inhibitors of hif and angiogenesis |
| 01/14/2010 | WO2010005581A1 Niacin compositions for reduction of amyloid beta peptide 42 (abeta 42) production and for treatment of alzheimer's disease (ad) |
| 01/14/2010 | WO2010005533A2 Compositions and methods for the treatment of ocular oxidative stress and retinitis pigmentosa |
| 01/14/2010 | WO2010005480A2 Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor |
| 01/14/2010 | WO2010005403A1 Dermatological composition for use in the treatment and/or prevention of skin diseases |
| 01/14/2010 | WO2010005046A1 Anti-angiogenic agent |
| 01/14/2010 | WO2010005004A1 Xanthine oxidase inhibitor and uric acid production inhibitor |
| 01/14/2010 | WO2010004982A1 Ameliorating or therapeutic agent for dyslipidemia |
| 01/14/2010 | WO2010004972A1 Nitrogen-containing aromatic heterocyclyl compound |
| 01/14/2010 | WO2010004385A1 Process for the preparation of pure 4'-[4-methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl]methyl]-2-biphenylcarboxylic acid |
| 01/14/2010 | WO2010004283A2 Therapy |
| 01/14/2010 | WO2010004197A2 Pyridino-pyridinone derivatives, preparation thereof, and therapeutic use thereof |
| 01/14/2010 | WO2010003996A1 Eprosartan compositions |
| 01/14/2010 | WO2010003295A1 Use of ginsenoside rb1 in preparing medicaments for treating dilated cardiomyopathy |
| 01/14/2010 | WO2009144551A3 Use of dronedarone or a pharmaceutically acceptable salt thereof, for the preparation of a medicament for regulating the potassium level in the blood |
| 01/14/2010 | WO2009142679A3 Methods for treating acute myocardial infarction |
| 01/14/2010 | WO2009134389A9 An anti-cd137 antibody as an agent in the treatment of inflammatory conditions |
| 01/14/2010 | WO2009124103A3 Combination therapies comprising par1 antagonists with par4 antagonists |
| 01/14/2010 | WO2009037586A3 Use of peptidic vasopressin receptor agonists |
| 01/14/2010 | WO2008133709A3 Targeted split biomolecular conjugates for the treatment of diseases, malignancies and disorders, and methods of their production |
| 01/14/2010 | US20100010073 Microrna (mirna) for the diagnosis and treatment of heart diseases |
| 01/14/2010 | US20100010061 Cb1 receptor modulators |
| 01/14/2010 | US20100010035 Novel Dual Action Receptors Antagonists (Dara) at the Ati and Eta Receptors |
| 01/14/2010 | US20100010024 Use of1,4-diaryl-dihydropyrimidine-2-on derivatives for treating pulmonary arterial hypertension |
| 01/14/2010 | US20100010020 Phosphodiesterase 4 inhibitors |
| 01/14/2010 | US20100010004 Inhibitors of histone deacetylase |
| 01/14/2010 | US20100009988 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 01/14/2010 | US20100009985 THERAPEUTICALLY USEFUL SUBSTITUTED HYDROPYRIDO [3,2,1-ij] QUINOLINE COMPOUNDS |
| 01/14/2010 | US20100009977 Process for the preparation of (R)-(+)-4-(Ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide-1,1-dioxide. |
| 01/14/2010 | US20100009939 Concurrent drugs |
| 01/14/2010 | US20100009919 Apolipoprotein A1 Mimetics and Uses Thereof |
| 01/14/2010 | US20100008971 Chewing composition comprising coenzyme q10 |
| 01/14/2010 | US20100008965 Biocompatible medical products having enhanced anti-thrombogenic properties |
| 01/14/2010 | US20100008956 Composition and combinations of carboxylic acid losartan in dosage forms |
| 01/14/2010 | US20100008913 Methods and compositions for treating platelet-related disorders |
| 01/14/2010 | US20100008908 Treatment of Heart Failure |
| 01/14/2010 | DE102008045152A1 Künstliche Sauerstoffträger und ihre Verwendung Artificial oxygen carriers and their use |
| 01/14/2010 | CA2730078A1 Nitrogen-containing aromatic heterocyclyl compound |
| 01/14/2010 | CA2730008A1 Eprosartan compositions |
| 01/14/2010 | CA2729833A1 Pyridino-pyridinone derivatives, preparation thereof, and therapeutic use thereof |
| 01/14/2010 | CA2729605A1 Compositions and methods for the treatment of ocular oxidative stress and retinitis pigmentosa |
| 01/14/2010 | CA2728213A1 Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor |
| 01/14/2010 | CA2728069A1 Means and methods for counteracting, delaying and/or preventing heart disease |
| 01/13/2010 | EP2143719A1 Pharmaceutical composition, food or beverage capable of enhancing sympathetic nerve activity |
| 01/13/2010 | EP2143444A1 Compositions for inhibition of anglogenesis |
| 01/13/2010 | EP2143434A1 Composition for promoting ketone compound formation |
| 01/13/2010 | EP2143427A1 Medicinal composition, food or drink having effect of enhancing parasympathetic nervous actions |
| 01/13/2010 | EP2142664A1 Estimation and biological consequences of oxidative metabolism |
| 01/13/2010 | EP2142551A1 Fused heterocyclic 11-beta-hydroxysteroid dehydrogenase type i inhibitors |
| 01/13/2010 | EP2142531A1 Benzimidazole cannabinoid agonists |
| 01/13/2010 | EP2142495A1 Substituted dibenzoic acid derivatives and use thereof |
| 01/13/2010 | EP2142206A1 Method of treating ischemic disorders |
| 01/13/2010 | EP2142205A1 Compositions and methods for increasing vascularization |
| 01/13/2010 | EP1651596B1 Novel derivatives of 4,4'-dithiobis-(3-aminobutane-1-sulfonates) and compositions comprising the same |
| 01/13/2010 | EP1435954B1 A PROCESS FOR THE PREPARATION OF HIGHlLY PUREAMLODIPINE BENZENESULFONATE |
| 01/13/2010 | EP1211242B1 Prostaglandin derivatives |
| 01/13/2010 | EP1144388B1 Acyl derivatives which treat vla-4 related disorders |
| 01/13/2010 | CN100580082C Lyophylization preparation of recombinant staphylokinase, its preparing method and application |
| 01/13/2010 | CN100580079C Neural progenitor cell populations |
| 01/13/2010 | CN100579984C Orally administered peptides to ameliorate atherosclerosis |
| 01/13/2010 | CN100579606C Use of whey permeate for the treatment of metabolic syndrome |
| 01/13/2010 | CN100579582C Combined use of enzyme inhibitors and pharmaceutical preparations thereof for the preparation of medicament for treatment and prophylaxis of arteriosclerosis, for the treatment and prevention of aller |
| 01/13/2010 | CN100579577C Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs |
| 01/13/2010 | CN100579570C Oral Chinese medicinal composition for treating apoplexia |
| 01/13/2010 | CN100579567C Use of Chinese medicine preparation in preparing medicine for defending coronary heart disease |
| 01/13/2010 | CN100579565C Preparation for treating chronic pulmonary heart disease and preparation method thereof |
| 01/13/2010 | CN100579558C Quality control method of particles for treating cardio-cerebral vascular diseases |
| 01/13/2010 | CN100579556C Preparation method of Chinese medicinal capsule for treating apoplexy |
| 01/13/2010 | CN100579547C Orally taken Chinese medicine composition for treating thromboangitis obliterans |
| 01/13/2010 | CN100579536C Preparation method for graininess medicine containing hirsutella hepia - cordyceps fungus powder |
| 01/13/2010 | CN100579529C Alprostadil freeze-dried emulsion and its preparation method |
| 01/13/2010 | CN100579528C Dispersion tablet for improving brain circulation |
| 01/13/2010 | CN100579526C Compound sustained-release pellet tablet containing nifedipine and atenolol and preparation thereof |
| 01/13/2010 | CN100579525C Sustained release preparation of licardipine hydrochloride and its preparing process |